mTOR inhibition and trastuzumab-emtansine (T-DM1) in HER2-positive breast cancer - David Casadevall; Anna Hernández?Prat; Sara García?Alonso; Oriol Arpí-Llucià; Sílvia Menéndez; Mengjuan Qin; Cristina Guardia; Beatriz Morancho; Francisco Javier Sánchez-Martín; Sandra Zazo; Elena Gavilán; Mohammad A. Sabbaghi; et al. (MOLECULAR CANCER RESEARCH, 2022)